Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?

The management of premature birth still remains unsatisfactory. Since the relative lack of efficiency and/or safety of current tocolytic agents have been highlighted, it is necessary to develop new uterorelaxant drugs deprived of important maternal and foetal side effects. Our work reported in this...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Bardou, Marc, Rouget, Céline, Breuiller-Fouché, Michèle, Loustalot, Catherine, Naline, Emmanuel, Sagot, Paul, Frydman, René, Morcillo, Esteban J, Advenier, Charles, Leroy, Marie-Josèphe, Morrison, John J
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2007
Ämnen:
Proceedings
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1892055/
https://ncbi.nlm.nih.gov/pubmed/17570158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2393-7-S1-S14
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk